Descriptor English: | Glucose-6-Phosphate Isomerase | ||||||
Descriptor Spanish: |
Glucosa-6-Fosfato Isomerasa
| ||||||
Descriptor Portuguese: | Glucose-6-Fosfato Isomerase | ||||||
Descriptor French: | Glucose 6-phosphate isomerase | ||||||
Entry term(s): |
Autocrine Motility Factor Factor, Autocrine Motility Glucose 6 Phosphate Isomerase Glucosephosphate Isomerase Isomerase, Glucose 6 Phosphate Isomerase, Glucose-6-Phosphate Isomerase, Glucosephosphate Isomerase, Phosphoglucose Isomerase, Phosphohexose Motility Factor, Autocrine Neuroleukin Phosphoglucose Isomerase Phosphohexose Isomerase Tumor Autocrine Motility Factor Tumor Cell Autocrine Motility Factor Tumor-Cell Autocrine Motility Factor |
||||||
Tree number(s): |
D08.811.399.475.200.350 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D005956 | ||||||
Scope note: | An aldose-ketose isomerase that catalyzes the reversible interconversion of glucose 6-phosphate and fructose 6-phosphate. In prokaryotic and eukaryotic organisms it plays an essential role in glycolytic and gluconeogenic pathways. In mammalian systems the enzyme is found in the cytoplasm and as a secreted protein. This secreted form of glucose-6-phosphate isomerase has been referred to as autocrine motility factor or neuroleukin, and acts as a cytokine which binds to the AUTOCRINE MOTILITY FACTOR RECEPTOR. Deficiency of the enzyme in humans is an autosomal recessive trait, which results in CONGENITAL NONSPHEROCYTIC HEMOLYTIC ANEMIA. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Entry Combination: |
deficiency:Anemia, Hemolytic, Congenital Nonspherocytic
deficiencia:Anemia Hemolítica Congénita no Esferocítica deficiência:Anemia Hemolítica Congênita não Esferocítica |
||||||
Registry Number: | EC 5.3.1.9 | ||||||
CAS Type 1 Name: | D-Glucose-6-phosphate ketol-isomerase | ||||||
Public MeSH Note: | 1998 (1965); see GLUCOSEPHOSPHATE ISOMERASE 1965-1997; for AUTOCRINE MOTILITY FACTOR see AUTOCRINE MOTILITY FACTOR 1992-2011; for NEUROLEUKIN see NEUROLEUKIN 1990-2011 |
||||||
History Note: | 1998(1965) |
||||||
DeCS ID: | 6101 | ||||||
Unique ID: | D005956 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1965/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2011/06/24 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes
|
Glucose-6-Phosphate Isomerase
- Preferred
Autocrine Motility Factor
- Narrower
Concept UI |
M0009354 |
Scope note | An aldose-ketose isomerase that catalyzes the reversible interconversion of glucose 6-phosphate and fructose 6-phosphate. In prokaryotic and eukaryotic organisms it plays an essential role in glycolytic and gluconeogenic pathways. In mammalian systems the enzyme is found in the cytoplasm and as a secreted protein. This secreted form of glucose-6-phosphate isomerase has been referred to as autocrine motility factor or neuroleukin, and acts as a cytokine which binds to the AUTOCRINE MOTILITY FACTOR RECEPTOR. Deficiency of the enzyme in humans is an autosomal recessive trait, which results in CONGENITAL NONSPHEROCYTIC HEMOLYTIC ANEMIA. |
Preferred term | Glucose-6-Phosphate Isomerase |
Entry term(s) |
Glucose 6 Phosphate Isomerase Glucosephosphate Isomerase Isomerase, Glucose 6 Phosphate Isomerase, Glucose-6-Phosphate Isomerase, Glucosephosphate Isomerase, Phosphoglucose Isomerase, Phosphohexose Phosphoglucose Isomerase Phosphohexose Isomerase |
Concept UI |
M0025255 |
Scope note | A secreted form of glucose-6-phosphate isomerase. |
Preferred term | Autocrine Motility Factor |
Entry term(s) |
Factor, Autocrine Motility Motility Factor, Autocrine Neuroleukin Tumor Autocrine Motility Factor Tumor Cell Autocrine Motility Factor Tumor-Cell Autocrine Motility Factor |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey